That’s what has fascinated the editors of Canada’s Top 100 Employers since the annual competition launched in 2000 to ...
From an estimated $150 billion of spending in 2024, the category is expected to mushroom up to roughly $200 billion by 2030, ...
MONTREAL, Nov. 14, 2024 (GLOBE NEWSWIRE) -- Knight Therapeutics Inc. (TSX: GUD) ("Knight"), a pan-American (ex-USA) specialty pharmaceutical company, announced today that Health Canada has approved ...
Many may now wonder whether Canada could be pressured to do the same ... when medicines with an older ingredient — ...